高级检索
中华临床医师杂志（电子版）
期刊首页
过刊列表
高级检索
稿件发表
• 临床研究 •
ENGLISH ABSTRACT
系统性红斑狼疮皮疹的临床分析
李文根
何雪春
何春媚
作者及单位信息
·
DOI： 10.3877/cma.j.issn.1674-0785.2018.04.008
Clinical analysis of rash in systemic lupus erythematosus
Li Wengen
He Xuechun
He Chunmei
Authors Info & Affiliations
Li Wengen
Department of Rheumatology, Meizhou People′s Hospital, Meizhou 514031, China
He Xuechun
He Chunmei
·
DOI： 10.3877/cma.j.issn.1674-0785.2018.04.008
273
0
0
0
0
0
PDF下载
APP内阅读
摘要

目的探讨系统性红斑狼疮（SLE）皮疹的临床意义。

方法回顾性分析梅州市人民医院2010年1月至2016年12月诊治的661例确诊的SLE患者，根据皮肤有无皮疹损害分为皮疹组及非皮疹组，收集2组患者的临床表现、实验室结果和疾病活动等资料。采用 χ 2 检验比较2组患者的各种临床表现的例数及实验室结果异常的例数，采用 t检验比较2组患者血清补体C3、C4水平及SLE疾病活动指数评分，采用Logistic回归分析皮疹与性别、起病年龄、临床表现及实验室结果的相关性。

结果661例SLE患者中338例(51.1%)出现皮疹损害。皮疹组患者的发热、口腔溃疡、脱发、关节炎发生率均高于非皮疹组（38.5% vs 30.3%；27.8% vs 19.2%；39.3% vs 25.1%；63.0% vs 51.4%），差异有统计学意义［ χ 2 =4.821， P=0.028； χ 2 =6.800， P=0.009； χ 2 =15.366， P<0.001； χ 2 =9.124， P=0.003］；皮疹组患者贫血的发生率低于非皮疹组（56.8% vs 64.4%），差异有统计学意义（ χ 2 =3.984， P=0.046）。免疫学结果显示，皮疹组患者血清C3水平低于非皮疹组［（0.47±0.27）g/L vs （0.55±0.27）g/L］，差异具有统计学意义（ χ 2 =-3.929， P<0.001）；皮疹组患者血清抗双联DNA抗体、抗Sm抗体的阳性率均高于非皮疹组（84.3% vs 77.7%；41.7% vs 27.9%），差异具有统计学意义（ χ 2 =4.707， P=0.030； χ 2 =13.941， P<0.001）。Logistic回归分析结果显示，SLE患者发生皮疹的危险因素为口腔溃疡（ OR=3.523， P<0.001）、脱发（ OR=4.549， P<0.001）、关节炎（ OR=1.758， P=0.002），起病年龄大（ OR=0.502， P=0.006）、无贫血（ OR=0.613， P=0.012）及补体C3水平正常（ OR=0.472， P=0.006）是保护因素。

结论皮疹是SLE常见的临床表现之一，皮疹损害可能预示SLE疾病过程中更易发生多系统损害，SLE患者发生皮疹损害与起病年龄、临床表现及血清学异常密切相关。

系统性红斑狼疮;皮疹;临床表现
ABSTRACT

ObjectiveTo investigate the clinical significance of rash in patients with systemic lupus erythematosus (SLE).

MethodsSix hundred and sixty-one SLE patients were enrolled into the study. The patients were divided into either a rash group or a control group (without rash manifestations) to compare the clinical findings, laboratory findings, and disease activity. The chi-square test was used to compare the number of clinical manifestations and the number of abnormal laboratory results in the two groups. The t-test was used to compare serum complement C3 and C4 levels and SLEDAI score between the two groups. Logistic regression was used to analyze the relation of rash with sex, onset age, clinical manifestations, and laboratory results.

ResultsAmong the 661 SLE patients, 338 (51.1%) had rash manifestations. The incidence of fever (38.5%), oral ulcer (27.8%), hair loss (39.3%), and arthritis (63.0%) in the rash group was significantly higher than that in the control group (38.5% vs 30.3%, χ 2 =4.821, P=0.028; 27.8% vs 19.2%, χ 2 =6.800, P=0.009; 39.3% vs 25.1%, χ 2 =15.366, P<0.001; and 63.0% vs 51.4%, χ 2 =9.124, P=0.003, respectively). The incidence of anemia in the rash group was lower than that in the control group (56.8% vs 64.4%, χ 2 =3.984, P=0.046). Immunological findings showed that the level of complement C3 was lower in the rash group than in the control group [(0.47±0.27) vs (0.55±0.27), χ 2 =-3.929, P<0.001]. SLE patients with rash had higher prevalence of anti-dsDNA antibody and anti-Sm antibody than those in the control group (84.3% vs 77.7%, χ 2 =4.707, P=0.030; and 41.7% vs 27.9%, χ 2 =13.941, P<0.001, respectively). The logistic regression analysis showed that oral ulcer ( OR=3.523, P<0.001), hair loss ( OR=4.549, P<0.001) and arthritis ( OR=1.758, P=0.002) were risk factors for SLE rash, while older age ( OR=0.502, P=0.006), no anemia ( OR=0.613, P=0.012), and normal complement C3 level ( OR=0.472, P=0.006) were protective factors.

ConclusionRash is one of the most common clinical manifestations of SLE and may be a marker of more severe systemic disease over time in SLE patients. Rash in SLE patients is closely related to age of onset, clinical manifestations, and serological abnormalities.

Systemic lupus erythematosus;Rash;Clinical manifestations
Corresponding author: Li Wengen, Email: mocdef.3ab618002700negil
Copyright by Chinese Medical Association
No content published by the journals of Chinese Medical Association may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journals without permission.
All articles published represent the opinions of the authors, and do not reflect the official policy of the Chinese Medical Association or the Editorial Board, unless this is clearly specified.
引用本文

李文根,何雪春,何春媚. 系统性红斑狼疮皮疹的临床分析[J/OL]中华临床医师杂志（电子版）,2018,12(4)：227-231.

DOI:10.3877/cma.j.issn.1674-0785.2018.04.008

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价

版权所有，未经授权，不得转载、摘编本刊文章，不得使用本刊的版式设计。

除非特别申明，本刊刊出的所有文章不代表中华医学会和本刊编辑委员会的观点。

本刊为电子杂志，以光盘形式出版。本册应读者需求按需印刷，随光盘免费赠阅，光盘如有质量问题，请向编辑部调换

系统性红斑狼疮（systemic lupus erythematosus，SLE）是一种自身免疫介导的，以免疫性炎症为突出表现的结缔组织病，可累及多个器官、多个系统。皮肤是其最常累及的系统之一，皮疹是最常见的皮肤损害表现，皮疹表现多种多样，可表现为蝶形红斑、盘状红斑等，其中又以颜面蝶形红斑最为典型。皮疹在中国SLE人群的发生率约为53.8% [ 1 ]。多种因素如性别、年龄、基因、环境、血清自身抗体等影响着SLE患者在整个病程中是否会出现皮疹。国外报道女性SLE患者颜面红斑的发生率高于男性患者 [ 2 ]，颜面红斑在成年发病的SLE患者更常见 [ 3 ]，颜面红斑与SLE患者血清中抗Sm抗体及抗核糖核蛋白抗体显著相关 [ 4 ]。本文对SLE患者的临床资料进行了回顾性分析，探讨SLE患者皮疹的临床意义，为SLE的临床诊疗提供依据。
试读结束，您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Li M , Zhang W , Leng X ,et al. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus[J]. Lupus, 2013,22(11):1192-1199.
返回引文位置Google Scholar
百度学术
万方数据
[2]
Boodhoo KD , Liu S , Zuo X . Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2016,95(29):e4272.
返回引文位置Google Scholar
百度学术
万方数据
[3]
Pravesh Kumar Bundhun , Alka Kumari , Feng Huang . Differences in clinical features observed between childhood-onsetversus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis[J]. Medicine (Baltimore), 2017,96(37):e8086.
返回引文位置Google Scholar
百度学术
万方数据
[4]
Li J , Leng X , Li Z ,et al. Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus[J]. J Immunol Res, 2014,2014:809389.
返回引文位置Google Scholar
百度学术
万方数据
[5]
Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997,40:1725.
返回引文位置Google Scholar
百度学术
万方数据
[6]
Gladman DD , Ibanez D , Urowitz MB . Systemic lupus erythematosus disease activity index 2000[J]. J Rheumatol, 2002,29:288-291.
返回引文位置Google Scholar
百度学术
万方数据
[7]
Osio-Salido E , Manapat-Reyes H . Epidemiology of systemic lupus erythematosus in Asia[J]. Lupus, 2010,19(12):1365-1373.
返回引文位置Google Scholar
百度学术
万方数据
[8]
Cervera R , Khamashta MA , Font J ,et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The European Working Party on Systemic Lupus Erythematosus[J]. Medicine (Baltimore), 1993,72(2):113-124.
返回引文位置Google Scholar
百度学术
万方数据
[9]
Cooper GS , Parks CG , Treadwell EL ,et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States[J]. Lupus, 2002,11(3):161-167.
返回引文位置Google Scholar
百度学术
万方数据
[10]
Rullo OJ , Tsao BP . Recent insights into the genetic basis of systemic lupus erythematosus[J]. Ann Rheum Dis, 2013,72Suppl:ii56-ii61.
返回引文位置Google Scholar
百度学术
万方数据
[11]
Medlin JL , Hansen KE , Fitz SR ,et al. A systematic review and meta-analysis of cutaneous manifestations in late-versus early-onset systemic lupus erythematosus[J]. Semin Arthritis Rheum, 2016,45(6):691-697.
返回引文位置Google Scholar
百度学术
万方数据
[12]
Zhang S , Su J , Li X ,et al. Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus[J]. Lupus, 2015,24(12):1267-1275.
返回引文位置Google Scholar
百度学术
万方数据
[13]
Sakiani S , Olsen NJ , Kovacs WJ . Gonadal steroids and humoral immunity[J]. Nat Rev Endocrinol, 2013,9(1):56-62.
返回引文位置Google Scholar
百度学术
万方数据
[14]
李文根，何雪春，何春媚,等. 不同年龄段初发系统性红斑狼疮的临床特点分析[J/CD]. 中华临床医师杂志(电子版), 2016,10(23):3549-3553.
返回引文位置Google Scholar
百度学术
万方数据
[15]
Wu CY , Li CF , Wu QJ ,et al. Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry IX: Clinical Features and Survival of Childhood-Onset Systemic Lupus Erythematosus in China[J]. Chin Med J (Engl), 2017,130(11):1276-1282.
返回引文位置Google Scholar
百度学术
万方数据
[16]
Chiewchengchol D , Murphy R , Morgan T ,et al. Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients[J]. Rheumatology (Oxford), 2014,53(8):1504-1512.
返回引文位置Google Scholar
百度学术
万方数据
[17]
Drucker AM , Su J , Mussani F ,et al. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis ofsystemic lupus erythematosus: results from a prospective cohort study[J]. Lupus, 2016,25(4):376-381.
返回引文位置Google Scholar
百度学术
万方数据
[18]
Huang X , Magder LS , Petri M . Predictors of Incident Seizure in Systemic Lupus Erythematosus[J]. J Rheumatol, 2016,43(3):565-575.
返回引文位置Google Scholar
百度学术
万方数据
[19]
Lu R , Robertson JM , Bruner BF ,et al. Multiple autoantibodies display association with lymphopenia, proteinuria, and cellular casts in a large, ethnically diverse SLE patient cohort[J]. Autoimmune Dis, 2012,2012:819634.
返回引文位置Google Scholar
百度学术
万方数据
[20]
Arroyo-Ávila M , Santiago-Casas Y , McGwin G Jr,et al. Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort[J]. Clin Rheumatol, 2015,34(7):1217-1223.
返回引文位置Google Scholar
百度学术
万方数据
[21]
Novak GV , Marques M , Balbi V ,et al. Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onsetsystemic lupus erythematosus[J]. Autoimmun Rev, 2017,16(2):132-135.
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
通信作者：李文根，Email： mocdef.3ab618002700negil
B

李文根,何雪春,何春媚.系统性红斑狼疮皮疹的临床分析[J/CD].中华临床医师杂志(电子版), 2018, 12(4): 227-231.

C
广东省医学科学技术研究基金项目 (A2016491)
评论 （0条）
注册
登录
时间排序
暂无评论，发表第一条评论抢沙发
最新推荐
更多
系统性红斑狼疮诊疗规范
沈南 等
中华内科杂志 2023,62(07)
儿童系统性红斑狼疮临床诊断与治疗专家共识(2022版)
中华医学会儿科学分会风湿病学组 等
中华实用儿科临床杂志 2022,37(09)
儿童系统性红斑狼疮治疗进展
曾月 等
中华实用儿科临床杂志 2021,36(10)
2020中国系统性红斑狼疮诊疗指南
中华医学会风湿病学分会 等
中华内科杂志 2020,59(03)
MedAI助手（体验版）
文档即答
智问智答
机器翻译
回答内容由人工智能生成，我社无法保证其准确性和完整性，该生成内容不代表我们的态度或观点，仅供参考。
生成快照
文献快照

你好，我可以帮助您更好的了解本文，请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持：

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号
小中大